Regional Anesthesia in Breast Surgery

Sponsor
Taipei Veterans General Hospital, Taiwan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04629612
Collaborator
(none)
120
1
2
12
10

Study Details

Study Description

Brief Summary

There is a trend that breast surgery can be done with peripheral nerve blockade and intravenous sedation, which reduces the side effects of general anesthesia such as nausea and vomiting, intubation discomfort and postoperative pain. The distribution of breast nerves is complex. Common nerve block methods are paravertebral blocks and pectoral nerve blocks. By monitoring the patient's heart rate variability change and measuring the patient's parasympathetic tone, the analgesic drug can be administered according to the patient's individual differences to avoid insufficient or excessive analgesic dose. The aim of this proposal is a prospective randomized controlled clinical trial is designed to evaluate changes in analgesia nociception index (ANI), surgical pleth index (SPI), postoperative opioid demand, and pain scores between patients who received regional anesthesia and those without in breast surgery patients under non-intubated surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Regional anesthesia
N/A

Detailed Description

Anesthesia has three elements: immobility, painlessness, and amnesia. To achieve these three factors depends on the balance between multiple factors, so multiple parameters need to be used for evaluation. In terms of subcortical function, pain indexes such as analgesia nociception index, surgical pleth index, etc. can be used to evaluate. By monitoring the parameters and comprehensive evaluation during the operation, the patient's condition can be fully understood. Opioids act on the central nervous system, making the nerve response slow and analgesic The effect is good, but there are many side effects, such as nausea and vomiting, drowsiness, respiratory depression, constipation, endocrine disorders, etc., and the central nervous system is suppressed by opioids, but the surrounding tissues are still damaged, releasing inflammatory mediators, causing immune dysfunction. Therefore, it is necessary to suppress inflammation and reduce the use of opioids, but also to effectively relieve pain. Nerve blockade is a powerful tool for this purpose. Local anesthetics are applied next to the nerves of the wound so that the pain signal cannot be transmitted to the central nervous system, reduce inflammatory mediators, reduce acute and chronic pain.

Breast surgery can be completed by peripheral nerve blockade and intravenous sedation, which can reduce the side effects of general anesthesia such as nausea and vomiting, intubation discomfort and postoperative pain. The distribution of breast nerves is complex, from the superficial cervical plexus, brachial nerve plexus, and thoracic vertebral nerves. At present, the commonly used nerve blocking methods include spinal nerve block, thoracic muscle block, brachial nerve block, and superficial nerve block. Blocking methods such as the cervical plexus, studies have shown that peripheral nerve blockade can reduce the amount of opioid analgesics during surgery.

This research plan is to design a randomized clinical trial to observe changes in the analgesic injury index (ANI), surgical pleth index (SPI), intraoperative and postoperative opiate demand, pain index, etc. inpatients with or without regional anesthesia under non-intubated breast surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
Double blind
Primary Purpose:
Treatment
Official Title:
Regional Anesthesia in Non-intubated Breast Surgery, a Randomized Controlled Trial
Anticipated Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Nov 30, 2021
Anticipated Study Completion Date :
Nov 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Regional anesthesia

Regional block applied according to surgical area

Procedure: Regional anesthesia
Regional anesthesia such as paravertebral block, pectoral block, superficial cervical plexus block, etc applies according to institution protocol

No Intervention: No Regional anesthesia

No regional anesthesia applied

Outcome Measures

Primary Outcome Measures

  1. Post-operative opioid use [From start of post operative care unit to discharge from post operative care unit, up to two hours]

    Total dose of post-operative morphine, tramadol, meperidine, etc calculated as morphine equivalent

  2. Post-operative opioid use [Second to 12th hour postoperatively]

    Total dose of post-operative morphine, tramadol, meperidine, etc calculated as morphine equivalent

  3. Post-operative opioid use [12th to 24th hour postoperatively]

    Total dose of post-operative morphine, tramadol, meperidine, etc calculated as morphine equivalent

  4. Post-operative opioid use [24th to 36th hour postoperatively]

    Total dose of post-operative morphine, tramadol, meperidine, etc calculated as morphine equivalent

  5. Post-operative opioid use [36th to 48th hour postoperatively]

    Total dose of post-operative morphine, tramadol, meperidine, etc calculated as morphine equivalent

  6. Post-operative opioid use [48th to 60th hour postoperatively]

    Total dose of post-operative morphine, tramadol, meperidine, etc calculated as morphine equivalent

  7. Post-operative opioid use [60th to 72nd hour postoperatively]

    Total dose of post-operative morphine, tramadol, meperidine, etc calculated as morphine equivalent

Secondary Outcome Measures

  1. Intra-operative opioid use [From start of induction to completion of surgery, total of 1-2 hours]

    Total dose of intra-operative remifentanil

  2. Intra-operative analgesia nociception index [From start of induction to completion of surgery, total of 1-2 hours]

    Intra-operative measurement of analgesia nociception index, on a scale on 0-100, higher on the scale indicate higher parasympathetic tone

  3. Intra-operative surgical pleth index [From start of induction to completion of surgery, total of 1-2 hours]

    Intra-operative measurement of surgical pleth index, on a scale on 0-100, lower on the scale indicate higher parasympathetic tone

  4. Post-operative nurse rated pain scale [Second postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

  5. Post-operative nurse rated pain scale [6th postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

  6. Post-operative nurse rated pain scale [12th postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

  7. Post-operative nurse rated pain scale [24th postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

  8. Post-operative nurse rated pain scale [36th postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

  9. Post-operative nurse rated pain scale [48th postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

  10. Post-operative nurse rated pain scale [60th postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

  11. Post-operative nurse rated pain scale [72nd postoperative hour]

    Post-operative measurement of nurse rated scale, on a scale on 0-10, higher the score indicate higher pain level

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Breast neoplasm require surgical resection of tumor

  • Surgical type: non-intubated breast surgery under intravenous anesthesia

Exclusion Criteria:
  • Contraindication for regional anesthesia: coagulopathy, infection

  • Previous breast surgery

  • Body mass index > 40

  • Chronic opioid use

  • Allergy to intravenous and regional anesthesia agents: Propofol, remifentanil, bupivacaine

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Anesthesiology, Taipei Veterans General Hospital Taipei Taiwan 112

Sponsors and Collaborators

  • Taipei Veterans General Hospital, Taiwan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Taipei Veterans General Hospital, Taiwan
ClinicalTrials.gov Identifier:
NCT04629612
Other Study ID Numbers:
  • 2020-05-001B
First Posted:
Nov 16, 2020
Last Update Posted:
Nov 16, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Taipei Veterans General Hospital, Taiwan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 16, 2020